Irbesartan vs Metformin
Irbesartan vs Metformin: Overview
This comparison examines the pharmacological differences between Irbesartan and Metformin.
Mechanism of Action
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Pharmacokinetics
Half-life: Irbesartan — 11-15 hours; Metformin — 4-9 hours.
Chemical Properties
Molecular Formula: Irbesartan — C25H28N6O; Metformin — C4H11N5.
Molecular Weight: Irbesartan — 428.5320 g/mol; Metformin — 129.1640 g/mol.
Type: Irbesartan — Small molecule; Metformin — Small molecule.